MEDIMI Stock Overview
Medimi AB (publ) develops, manufactures, and markets e-health solutions in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Medimi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.016 |
| 52 Week High | kr0.08 |
| 52 Week Low | kr0.013 |
| Beta | -0.38 |
| 1 Month Change | -22.86% |
| 3 Month Change | -47.74% |
| 1 Year Change | -76.52% |
| 3 Year Change | -96.76% |
| 5 Year Change | -95.79% |
| Change since IPO | -99.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDIMI | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -17.3% | 1.6% | 1.8% |
| 1Y | -76.5% | -9.0% | 10.7% |
Return vs Industry: MEDIMI underperformed the Swedish Medical Equipment industry which returned -9% over the past year.
Return vs Market: MEDIMI underperformed the Swedish Market which returned 10.7% over the past year.
Price Volatility
| MEDIMI volatility | |
|---|---|
| MEDIMI Average Weekly Movement | 21.8% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.9% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: MEDIMI's share price has been volatile over the past 3 months.
Volatility Over Time: MEDIMI's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 6 | Alexander Johansson | www.medimiab.com |
Medimi AB (publ) develops, manufactures, and markets e-health solutions in Sweden. It offers Medimi Smart, a comprehensive system for medicine handling; and MedimiFlex, an administration system. The company was formerly known as MedicPen AB (publ) and changed its name to Medimi AB (publ) in May 2021.
Medimi AB (publ) Fundamentals Summary
| MEDIMI fundamental statistics | |
|---|---|
| Market cap | kr17.47m |
| Earnings (TTM) | -kr14.25m |
| Revenue (TTM) | kr3.63m |
4.8x
P/S Ratio-1.2x
P/E RatioIs MEDIMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDIMI income statement (TTM) | |
|---|---|
| Revenue | kr3.63m |
| Cost of Revenue | kr1.60m |
| Gross Profit | kr2.03m |
| Other Expenses | kr16.28m |
| Earnings | -kr14.25m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 55.94% |
| Net Profit Margin | -392.89% |
| Debt/Equity Ratio | 0% |
How did MEDIMI perform over the long term?
See historical performance and comparison